MEOH vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

MEOH

39.8
AI Score
VS
CBT Wins

CBT

65.0
AI Score

Investment Advisor Scores

MEOH

40score
Recommendation
AVOID NEW MONEY

CBT

65score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MEOH CBT Winner
Forward P/E 10.352 9.9404 CBT
PEG Ratio 0.1982 1.0017 MEOH
Revenue Growth 75.2% 6.4% MEOH
Earnings Growth 164.7% -93.7% MEOH
Tradestie Score 39.8/100 65.0/100 CBT
Profit Margin 2.1% 5.2% CBT
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD CBT

Relative Price Performance (Last 90 Days)

MEOH 1M: -3.3% · 3M: +33.7% CBT 1M: -6.3% · 3M: -11.4%

Current Technical Phase

MEOH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.5 · Price: $58.60

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 41

RSI (14): 40.8 · Price: $77.65

Fundamentals Snapshot

Metric MEOH CBT
Market Cap — —
Forward P/E 9.9 10.9
Trailing P/E 66.7 21.8
Revenue (TTM) — —
Revenue Growth 0.8% 0.1%
Gross Margin 0.3% 0.2%
Operating Margin 0.4% 0.1%
EPS 0.88 3.53
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CBT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.